Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2015 / Article

Corrigendum | Open Access

Volume 2015 |Article ID 760692 | https://doi.org/10.1155/2015/760692

Mao-Lin Ho, Yih-Shou Hsieh, Jia-Yuh Chen, Kuo-Shuen Chen, Jia-Jing Chen, Wu-Hsien Kuo, Shu-Jiuan Lin, Pei-Ni Chen, "Corrigendum to “Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo", Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 760692, 2 pages, 2015. https://doi.org/10.1155/2015/760692

Corrigendum to “Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo

Received05 Nov 2015
Accepted11 Nov 2015
Published18 Nov 2015

We have noticed a misplaced figure in our paper “Antimetastatic Potentials of Dioscorea nipponica on Melanoma In Vitro and In Vivo” [1]. There is an error that occurred during uploading Figure (e). The published microscopy image of cell invasion for treatment of Dioscorea nipponica ethyl acetate extracts (DNE3) on B16F10 cells is incorrect. We have attached a correct version (Figure 4(e)).

References

  1. M.-L. Ho, Y.-S. Hsieh, J.-Y. Chen et al., “Antimetastatic potentials of Dioscorea nipponica on melanoma in vitro and in vivo,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 507920, 13 pages, 2011. View at: Publisher Site | Google Scholar

Copyright © 2015 Mao-Lin Ho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views688
Downloads439
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.